The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.

Autor: Shehata AHF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Egypt., Ahmed AF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Egypt. Electronic address: shaimaa.faissal@minia.edu.eg., Abdelrehim AB; Department of Biochemistry and Toxicology, Faculty of Pharmacy, Minia University, Egypt., Heeba GH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Egypt.
Jazyk: angličtina
Zdroj: Life sciences [Life Sci] 2020 Jul 01; Vol. 252, pp. 117679. Date of Electronic Publication: 2020 Apr 20.
DOI: 10.1016/j.lfs.2020.117679
Abstrakt: Aim: The neuronal damage and accompanied functional deficits induced by cerebral ischemia are among the most common causes of disabilities in adults. Activation of subtypes of peroxisome proliferator-activated receptors (PPARs); PPAR-α and PPAR-γ have shown neuroprotective effects in different neurodegenerative diseases including stroke. Thus, this study aimed to compare the effects of two different agonists: PPAR-α (fenofibrate) and PPAR-γ (pioglitazone) as well as the effect of their combination in ameliorating post-ischemia behavioral deficits.
Methods: Male Wistar rats were either pretreated with vehicle, fenofibrate (100 mg/kg/day p.o), pioglitazone (10 mg/kg/day p.o) or their combination for 14 days prior to bilateral common carotid artery occlusion followed by reperfusion for 24 hoursh. The sensory motor functions of rats were assessed, then rats were sacrificed to determine infarct volume and histopathological changes as well as oxidative stress, inflammatory and apoptotic markers in the brain tissue.
Key Findings: Pre-treatment with fenofibrate and pioglitazone in addition to their combination improved neurobehavioral dysfunction, reduced cerebral infarct volume, attenuated inflammatory and apoptotic markers and ameliorated histopathological changes in I/R injured rats. The effect of pioglitazone in cerebral cortex was higher than its corresponding effect in fenofibrate while the combined administration of both drugs had additive neuroprotective effect and normalized inflammatory and apoptotic mediators in ischemic rats.
Significance: The study compared the neuroprotective effects of PPAR-α and PPAR-γ agonists, and tested the impact of their combination. We concluded that no additional benefits on the functional outcomes might be gained upon their combination.
(Copyright © 2020 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: